Medindia

X

Senior GE Executive to lead IMRIS Sales team in the U.S.

Saturday, May 31, 2008 General News J E 4
Advertisement
WINNIPEG, May 30 /PRNewswire-FirstCall/ - Rami Liebenthal, Executive VicePresident of IMRIS, a global leader in surgical imaging, is pleased toannounce the appointment of Don Rice as Vice President, responsible for Salesin the U.S. market.

Don joins IMRIS after spending 23 years with GE Healthcare, where he ledsales efforts focused primarily on medical imaging equipment. His expertiseincludes senior sales management as well as the business development oftargeted healthcare sectors.

"Don's broad range of skills and strategic capabilities will definitelyassist IMRIS as we continue our rapid growth in the U.S. marketplace," saidMr. Liebenthal. "His in-depth understanding of the healthcare environmentcombined with his leadership ability is a great addition to our already strongteam."

In addition to the company's growing penetration in the North Americanmarket, IMRIS now has offices in China, Australia, India and Europe.

About IMRIS

IMRIS (TSX: IM) is a global leader in providing fully integrated, advancedsurgical imaging solutions designed to measurably improve patient outcomes.The company's flagship product, IMRISneuro, utilizes patented technology thatallows a high field MRI scanner to move in to the operating room on demand,providing imaging during the surgical procedure without compromising patientsafety. This unique and innovative system has been validated by leadingneurosurgeons around the world for use in world-class neuroscience centers.

For more information, visit www.imris.com.

SOURCE IMRIS Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
New Data on MAGE-A3 Cancer Immunotherapy Support P...
S
Vion Pharmaceuticals to Present Clinical Data on C...